KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
88 hedge funds and large institutions have $35.2M invested in Chinook Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
88
Holding in Top 10
–
Calls
–
Puts
$2K
Top Buyers
| 1 | +$1.07M | |
| 2 | +$981K | |
| 3 | +$570K | |
| 4 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$205K |
| 5 |
D.E. Shaw & Co
New York
|
+$204K |
Top Sellers
| 1 | -$2.71M | |
| 2 | -$1.19M | |
| 3 | -$341K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$304K |
| 5 |
Goldman Sachs
New York
|
-$225K |